Dow's Merck Bails On Cholesterol Drug, Prodding Shares Down
Dow component Merck said late Wednesday it won't submit applications for approval of a cholesterol drug.
Dow component Merck said late Wednesday it won't submit applications for approval of a cholesterol drug.